Better Buy: Moderna vs. BioCryst Pharmaceuticals

BioCryst Pharmaceuticals (NASDAQ: BCRX) and Moderna (NASDAQ: MRNA) are both biotech companies developing products to combat the COVID-19 pandemic, but the similarities end there. Each company has a distinct core competency and a different approach to growth.

If you're a speculator or a value hunter, one of these two stocks may have a place in your portfolio. But which stock is the better buy, and which will lead to lackluster portfolio performance? As with many issues in the biotech market today, the answer to this question circles back to COVID-19.

Image source: Getty Images.

Continue reading

Source Fool.com